Timlioǧlu, Ö. Et Al. 1999. The effect of EGb 761 on the doxorubicin cardiomyopathy. Research Communications in Molecular Pathology and Pharmacology , vol.106, no.3 , 181-192.

Timlioǧlu, Ö., Kutsal, Ş., Özkur, M., Uluoǧlu, Ö., Aricioǧlu, A., ÇEVİK, C., ... Düzgün, E.(1999). The effect of EGb 761 on the doxorubicin cardiomyopathy. Research Communications in Molecular Pathology and Pharmacology , vol.106, no.3, 181-192.

Timlioǧlu, Ö. Et Al. "The effect of EGb 761 on the doxorubicin cardiomyopathy," Research Communications in Molecular Pathology and Pharmacology , vol.106, no.3, 181-192, 1999

Timlioǧlu, Ö. Et Al. "The effect of EGb 761 on the doxorubicin cardiomyopathy." Research Communications in Molecular Pathology and Pharmacology , vol.106, no.3, pp.181-192, 1999

Timlioǧlu, Ö. Et Al. (1999) . "The effect of EGb 761 on the doxorubicin cardiomyopathy." Research Communications in Molecular Pathology and Pharmacology , vol.106, no.3, pp.181-192.

@article{article, author={Ö. Timlioǧlu Et Al. }, title={The effect of EGb 761 on the doxorubicin cardiomyopathy}, journal={Research Communications in Molecular Pathology and Pharmacology}, year=1999, pages={181-192} }